The overriding purpose of the Functional Genomics Core (FGC) is to provide to the Scripps NeuroAIDS Preclinical Studies (SNAPS) Center Investigators relevant state of the art technologies and assays for gene function analysis. The SNAPS center Investigators recognize there is likely not to be a single mechanistic cause of CNS dysfunction in NeuroAIDS and therefore have evolved combinatorial and multi- disciplinary research approaches to the examination of basic mechanisms in understanding the pathogenesis of HIV infection in the CNS. The FGC aims to compliment and extend the synergy of our research efforts in this multi-disciplinary research setting, to identify and understand the function of key molecular genetic alterations in the CNS in response to viral and/or host response related perturbations relative to the various neuroAIDS models. In effect, the FGC will provide services and support that facilitate the application of functional genomics to advance our understanding of the pathogenesis of neuroAIDS. The overall specific aims of the FGC are: (1) To provide high-density gene expression analysis using in-house constructed DNA microarrays. In addition, support and advice will be given to Investigators concerning the possible application in their studies of commercially available (e.g. Affymetrix and Incyte) microarray services. (2) To provide multi-probe RNase protection assays to study in more specific and quantitative detail the regulation of candidate genes identified by DNA microarray analysis. (3) To perform single and dual label in situ hybridization procedures for the anatomic and cellular localization of expressed candidate genes. (4) To continually enhance the utility, relevance and ensure services remain state of the art, the FGC will undertake to generate and add new gene probes to the existing DNA microarray, RNase protection and in situ hybridization assays. (5) To provide support to CSPAR Investigators in all aspects of functional genomics. (7) To interact closely with the Administrative Core and other research cores and Investigators to fulfill the obligations of the FGC in the education, outreach and collaborative activities of the CSPAR center.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
1P30MH062261-01
Application #
6221862
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2000-09-30
Project End
2005-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Sathyanesan, Monica; Watt, Michael J; Haiar, Jacob M et al. (2018) Carbamoylated erythropoietin modulates cognitive outcomes of social defeat and differentially regulates gene expression in the dorsal and ventral hippocampus. Transl Psychiatry 8:113
Zhou, Tian; Su, Hang; Dash, Prasanta et al. (2018) Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials 151:53-65
Thangaraj, Annadurai; Periyasamy, Palsamy; Liao, Ke et al. (2018) HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy. Autophagy 14:1596-1619
Kevadiya, Bhavesh D; Ottemann, Brendan M; Thomas, Midhun Ben et al. (2018) Neurotheranostics as personalized medicines. Adv Drug Deliv Rev :
Wiesman, Alex I; O'Neill, Jennifer; Mills, Mackenzie S et al. (2018) Aberrant occipital dynamics differentiate HIV-infected patients with and without cognitive impairment. Brain 141:1678-1690
Periyasamy, Palsamy; Thangaraj, Annadurai; Guo, Ming-Lei et al. (2018) Epigenetic Promoter DNA Methylation of miR-124 Promotes HIV-1 Tat-Mediated Microglial Activation via MECP2-STAT3 Axis. J Neurosci 38:5367-5383
Zhou, Tian; Lin, Zhiyi; Puligujja, Pavan et al. (2018) Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals. Nanomedicine (Lond) 13:871-885
Yang, Lu; Niu, Fang; Yao, Honghong et al. (2018) Exosomal miR-9 Released from HIV Tat Stimulated Astrocytes Mediates Microglial Migration. J Neuroimmune Pharmacol 13:330-344
Lin, Zhiyi; Gautam, Nagsen; Alnouti, Yazen et al. (2018) ProTide generated long-acting abacavir nanoformulations. Chem Commun (Camb) 54:8371-8374
McMillan, JoEllyn; Szlachetka, Adam; Zhou, Tian et al. (2018) Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques. AIDS :

Showing the most recent 10 out of 374 publications